Autonomix Granted U.S. Patent No. 12,544,131
Autonomix announced the United States Patent and Trademark Office has issued U.S. Patent No. 12,544,131. The newly granted patent covers catheter-based transvascular tools and systems designed to operate from within a bodily lumen, where deployable probes penetrate into and/or through a lumen wall to access tissue and nerves located outside the vessel. The patent includes claims relating to multi-site electrophysiological sensing, incorporating sensing at a target site, secondary site, and reference site to improve signal quality and procedural confidence. It also encompasses methods for assessing procedural completion based on electrophysiological signal processing, including detection of changes in neural activity patterns to assess treatment effect and procedural outcomes.
